IDUs were randomized in a trial comparing the standard HBV vaccination schedule ( 0 , 1 , and 6 months ) to an accelerated schedule ( 0 , 1 , and 2 months ) and participation data were analyzed to identify determinants of completion of the three-dose vaccine series .